Article
Nonmyeloablative conditioning with busulfan before matched littermate bone marrow transplantation results in reversal of the disease phenotype in canine leukocyte adhesion deficiency.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation - 1 Oct 2005
Sokolic Robert A, Bauer Thomas R, Gu Yu-Chen, Hai Mehreen, Tuschong Laura M, Burkholder Tanya, Colenda Lyn, Bacher John, Starost Matthew F, Hickstein Dennis D
Abstract excerpt
Leukocyte adhesion deficiency (LAD)-1, a primary immunodeficiency disease caused by molecular defects in the leukocyte integrin CD18 molecule, is characterized by recurrent, life-threatening bacterial infections. Myeloablative hematopoietic stem cell transplantation is the only curative treatment for LAD-1. Recently, canine LAD (CLAD) has been shown to be a valuable animal model for the preclinical testing of...
Topics
- Animals
- Bone Marrow Transplantation
- Busulfan
- Cyclosporine
- Dog Diseases
- Dogs
- Follow-Up Studies
- Immunosuppressive Agents
- Leukocyte-Adhesion Deficiency Syndrome
